SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHD.L Regulatory News (PHD)

  • There is currently no data for PHD

Trading Update

25 Aug 2020 07:00

RNS Number : 0171X
PROACTIS Holdings PLC
25 August 2020
 

25 August 2020

Proactis Holdings PLC

Trading Update

Proactis Holdings PLC, the business spend management solution provider, provides an update on trading for the financial year ended 31 July 2020.

Trading Update

The Group's performance was in line with board and market expectations for the year despite the emergence of the COVID-19 global pandemic during the period, demonstrating the resilience of the Group's business model.

New business deal intake for the year was at a record high as the Group secured a 29% increase in total contract value ("TCV") of £14.6m (2019: £11.3m). The Board maintains its expectation of increased levels of TCV over the coming years, with a growing pipeline and momentum building following the roll-out of the Group's new go-to-market strategy.

The Board expects to report revenues of £49.2m for the year and adjusted EBITDA of £11.8m.

Net bank debt as at 31 July 2020 was £37.1m (31 July 2019: £36.5m) with the year-end position impacted by the timing of settlement in certain accounts receivable balances as well as lower transaction volumes due to COVID-19 in the Group's outsourced services business. If volumes had been at the same level as prior period reporting dates, net debt would have been approximately £36.0m.

This encouraging performance has been achieved despite the impact of COVID-19 which has caused slower pipeline conversion of the Group's new supplier-paid solution, bePayd, with prospects temporarily shifting priorities. The Board remains encouraged by the levels of interest in this solution and anticipates progress in the near term.

Overall, the outlook for the new financial year remains encouraging, although the Board remains cautious given the macro-economic backdrop and associated risk across new business trends, project implementation deferrals, volume-based contracts and customer solvency. The Board looks forward to the next 12 months and is confident of delivering significant value with the business now well positioned and with a pipeline that is building.

Tim Sykes, CEO commented:

"We delivered an encouraging new business performance in the period against a challenging macro-economic backdrop, demonstrating the effectiveness of our strategy, the resilience of our business model and the ability of our teams to deliver despite a change in working practices.

"Moving forwards, we expect to make further progress in growing the rate of new business intake and we will continue to focus on retention and margin improvement to drive cash flow, whilst maintaining a measured level of investment to support our long-term growth ambitions.

"There can be no certainty about the impact that the pandemic will have on our markets. Demand has been marginally subdued through this period and sales processes have been more challenging because of competing priorities but the Group is well-positioned to continue to capitalise on the opportunities available to it. Accordingly, we expect to continue to make further progress and we remain confident in our ability to accelerate growth whilst further improving profitability and cash flow."

 

Financial expectations noted above are unaudited and are subject to the completion of year-end financial close and audit processes.

 

The information contained within this announcement is deemed to constitute inside information for the purposes of article 7 of the market abuse regulation (EU) no. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

For further information, please contact:

Proactis Holdings PLC

Tim Sykes, Chief Executive Officer

 

01937 545070 x1115 investorcontact@proactis.com

finnCap Ltd

Carl Holmes/Matthew Radley - Corporate Finance

Andrew Burdis/Richard Chambers - ECM

 

0207 220 0500

 

 

Alma PR

Rebecca Sanders-Hewett, Sam Modlin, David Ison

 

020 3405 0205

Proactis@almapr.co.uk

 

Notes to Editors:

Proactis creates, sells and maintains software and services which enable organisations to streamline, control and monitor all indirect expenditure. Its solutions are used in approximately 1,100 buying organisations around the world from the commercial, public and not-for-profit sectors.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUSRKRRUUWUAR
Date   Source Headline
22nd Jan 20187:00 amRNSIssue of Equity
18th Jan 20187:00 amRNSFiling of Tender Offer for Hubwoo
15th Jan 20187:00 amRNSIssue of Equity
5th Jan 201810:04 amRNSTR-1: Notification of major holdings
18th Dec 201710:40 amRNSResult of AGM
7th Dec 201710:06 amRNSIssue of Equity
5th Dec 20173:09 pmRNSHolding(s) in Company
30th Nov 20177:00 amRNSAnnual Report and Accounts & Notice of AGM
13th Nov 20177:00 amRNSDirector/PDMR Shareholding
10th Nov 20177:00 amRNSIssue of Equity
3rd Nov 20172:36 pmRNSHolding(s) in Company
13th Oct 20177:00 amRNSDirector/PDMR Shareholding
11th Oct 20177:00 amRNSFinal Results
5th Sep 201712:19 pmRNSIssue of Equity
29th Aug 20177:00 amRNSGrant of Options
22nd Aug 20177:00 amRNSTrading Update & Notice of Results
7th Aug 20177:00 amRNSCompletion of Acquisition and Re-admission
31st Jul 201712:00 pmRNSResult of General Meeting and Total Voting Rights
20th Jul 20177:00 amRNSHolding(s) in Company
10th Jul 20172:28 pmRNSHolding(s) in Company
10th Jul 201711:56 amRNSHolding(s) in Company
7th Jul 20178:00 amRNSSch 1 - Proactis Holdings Plc
7th Jul 20177:00 amRNSProposed Acquisition, Placing & Notice of GM
3rd May 20177:00 amRNSIssue of Equity and Total Voting Rights
26th Apr 20177:00 amRNSInterim Results
4th Apr 20177:00 amRNSHolding(s) in Company
3rd Apr 20176:19 pmRNSHolding(s) in Company
13th Mar 20177:00 amRNSIssue of Equity and Total Voting Rights
20th Feb 20177:00 amRNSTrading Statement
30th Jan 20177:00 amRNSDirector Shareholdings, Issue of Equity & TVR
19th Dec 201612:49 pmRNSResult of AGM
19th Dec 20167:00 amRNSDirectorate Change
29th Nov 20167:00 amRNSIssue of Equity
28th Nov 20162:47 pmRNSAnnual Report and Accounts & Notice of AGM
28th Nov 20162:40 pmRNSHolding(s) in Company
17th Nov 20167:00 amRNSCompletion of Acquisition
10th Nov 201611:36 amRNSResult of Placing
10th Nov 201611:05 amRNSSecond Price Monitoring Extn
10th Nov 201611:00 amRNSPrice Monitoring Extension
10th Nov 20167:00 amRNSProposed Acquisition and Placing
12th Oct 20167:00 amRNSPreliminary Results
9th Sep 20163:04 pmRNSHolding(s) in Company
7th Sep 20165:07 pmRNSHolding(s) in Company
19th Aug 201610:42 amRNSHolding(s) in Company
11th Aug 20167:00 amRNSTrading Update & Notice of Results
29th Jul 20167:00 amRNSDirector/PDMR Shareholding
21st Jul 20167:00 amRNSIssue of Equity
14th Jul 201612:42 pmRNSHolding(s) in Company
6th Jul 20167:00 amRNSIssue of Equity
20th Jun 20167:00 amRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.